GLP-1s and Metabolic Health After 50

A practical, evidence-led guide to GLP-1s for weight loss after 50: choosing a drug, getting it and paying for it, holding onto your muscle, and what is coming next. I take tirzepatide myself and write from patient experience, with links to the evidence.

By Gunnar · Patient experience, not medical advice · Updated July 2026

Bar chart, weight loss in each drug's pivotal obesity trial at top dose: retatrutide 28% and CagriSema 23% (pipeline); tirzepatide Zepbound 22%, semaglutide Wegovy HD 21%, orforglipron Foundayo 12% (approved).
Study details and sources
DrugTrialDoseWeeksWeight loss
Retatrutide (in trials)TRIUMPH-112 mg8028%
CagriSema (filed)REDEFINE 12.4/2.4 mg6823%
Tirzepatide (Zepbound)SURMOUNT-115 mg7222%
Semaglutide (Wegovy HD)STEP UP7.2 mg7221%
Orforglipron (Foundayo)ATTAIN-117.2 mg tablet7212%
Reported peak mean weight loss at the top studied dose. Trials differ in patients, duration, and analysis method, so these are a rough map, not a head-to-head.

What men over 50 should know

Who they’re for. These are prescription treatments for obesity, or for being overweight with a related health problem, not casual cosmetic weight loss. At their top doses the strongest approved injections now average around 20 percent of body weight in trials, and the pills generally do less. Those are averages, not promises, and the chart above is a useful map of the field, not a ranking. What gets lost is that the benefit is not only the scale. Across trials, these drugs improved blood sugar and blood pressure; some reduced sleep-apnea severity, and semaglutide reduced major cardiovascular events in people with established cardiovascular disease. That is why I file them under metabolic health, not just weight loss.

Muscle and side effects. How much of the loss is fat depends on what you do while it comes off. Large weight losses can include lean tissue, so strength training and adequate protein help preserve muscle, strength, and function. Tolerance varies just as much. Some people barely notice the drug, others fight nausea and constipation for weeks, and the dose climbs slowly for a reason. Someone else’s experience does not predict yours.

Long-term treatment and cost. This is usually a long-term drug: stop, and the weight tends to return, because the biology that made you heavy is still there, so plan for staying on or for a real maintenance plan. And which drug you actually end up on is often decided by your insurance and your budget rather than by the chart, which is what the cost and access section below is for.

Start here

Access & Cost

Muscle & Recomposition

The Pipeline

Latest in GLP-1s

View all GLP-1 articles →

Explore more

Scroll to Top